Severe acute respiratory syndrome coronavirus 2 infections are associated with greater risk
of both arterial and venous thromboembolic events. Pathophysiology and Clinical …

Since severe acute respiratory syndrome coronavirus 2 led to a world pandemic, extensive
research has been conducted to identify its characteristics and form an appropriate …

Background Randomized clinical trials in non-critically ill COVID-19 patients showed that
therapeutic-dose heparin increased survival with reduced organ support as compared with …

The prevalence of venous thromboembolism is high in patients with COVID-19, despite
prophylactic anticoagulation. The evidence that supports the preferred thromboprophylaxis …

Purpose Romania is one of the European countries that has been hit the hardest by the
severe acute respiratory syndrome caused by the new coronavirus SARS-CoV-2, with over …

Abstract Coronavirus disease 19 (COVID-19) is a systematic multitropic disease. Sustaining
blood homeostasis is a mission of multiple factors includes procoagulant and anticoagulant …

Regimens for managing thromboembolic complications of COVID-19 are still not very well
established. The present study compares the clinical characteristics and outcomes of …

Abstract Background Coronavirus disease 2019 (COVID-19) is associated with provoked
thrombo-inflammatory responses. Early in the COVID-19 pandemic this was thought to …

Abstract Background Coronavirus disease 2019 (COVID-19), caused by a strain of
coronavirus known as severe acute respiratory syndrome coronavirus 2, is well known to …

心血管疾病是新型冠状病毒肺炎(新冠肺炎) 最为常见的合并症, 在新冠肺炎大流行期间降压,
降脂, 抗血小板, 抗凝, 降糖及抗心律失常等心血管系统常用药物的安全性和有效性尚未形成统一 …